Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial-Reference-Cited by-同舟云学术

Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial

Published:2023-04-18 Issue:5 Volume:49 Page:530-544
ISSN:0342-4642
Container-title:Intensive Care Medicine
language:en
Short-container-title:Intensive Care Med

Author:

Roquilly Antoine^ORCID,Francois Bruno,Huet Olivier,Launey Yoann,Lasocki Sigismond,Weiss Emmanuel,Petrier Melanie,Hourmant Yannick,Bouras Marwan,Lakhal Karim,Le Bel Cecilia,Flattres Duchaussoy Delphine,Fernández-Barat Laia,Ceccato Adrian,Flet Laurent,Jobert Alexandra,Poschmann Jeremie,Sebille Veronique,Feuillet Fanny,Koulenti Despoina,Torres Antoni,Grillot Nicolas,Asehnoune Karim,Bourdiol Alexandre,Demeure dit latte Dominique,Armaganidis Apostolos,Nesseler Nicolas,Seguin Philippe,

Funder

H2020 Excellent Science

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00134-023-07065-0.pdf

Reference47 articles.

1. Sipilä PN, Heikkilä N, Lindbohm JV et al (2021) Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort. Lancet Infect Dis 21:1557–1567. https://doi.org/10.1016/s1473-3099(21)00144-4

2. Bekaert M, Timsit J-F, Vansteelandt S et al (2012) Attributable mortality of ventilator-associated pneumonia. Am J Resp Crit Care Med 184:1133–1139. https://doi.org/10.1164/rccm.201105-0867oc

3. Eber MR, Laxminarayan R, Perencevich EN, Malani A (2010) Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia. Arch Intern Med 170:347–353. https://doi.org/10.1001/archinternmed.2009.509